Michael Logerfo is President & CLO at Sagent Pharmaceuticals, Inc. (SGNT). They have made 7 open-market trades across 1 company since 2011, most recently 2016-02-25.
CIK 0001518010
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $47K since 2011, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGNT | 53,292 | — |
Shares reported on the most recent Form 4, priced at the 2016-02-26 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGNT | SELL | 2014-02-27 | 2014-02-28 | $21.43 | $43K | N/A | N/A | N/A |
| SGNT | SELL | 2014-02-20 | 2014-02-24 | $21.93 | $187K | N/A | N/A | N/A |
| SGNT | SELL | 2012-11-16 | 2012-11-20 | $14.65 | $134K | N/A | N/A | N/A |
| SGNT | SELL | 2012-11-14 | 2012-11-16 | $14.40 | $144K | N/A | N/A | N/A |
| SGNT | SELL | 2012-05-25 | 2012-05-29 | $15.86 | $111K | N/A | N/A | N/A |
| SGNT | BUY | 2012-05-17 | 2012-05-18 | $15.69 | $31K | N/A | N/A | N/A |
| SGNT | BUY | 2011-04-20 | 2011-04-20 | $16.00 | $16K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.